NCT00323479
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +6 more
- Locations
-
- Research Site Bordeaux, France
- Research Site Caen, France
- Research Site Lyon, France
- Research Site Paris, France
Clinical trial condition
Early Breast Cancer
Explore clinical trials studying Early Breast Cancer. Study availability and eligibility vary by location and protocol.
52 public trials
13 recruiting studies
Early Breast Cancer trial results
Completed
Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer
NCT00713141
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
- Locations
-
- National University Hospital Singapore
NCT00558168
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
- Locations
-
Not specified
NCT04961996
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
- Locations
-
- Southern Cancer Center Daphne, Alabama, United States
- CBCC Global Research Inc., at Comprehensive Blood and Cancer Center Bakersfield, California, United States
- St Joseph Heritage Healthcare Fullerton, California, United States
- Long Beach Memorial Medical Center Long Beach, California, United States
Active, Not Recruiting
Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer
NCT04733118
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
- Locations
-
- UMHAT Sveti Ivan Rilski EAD Department of Medical Oncology Sofia, Bulgaria
- Praxisnetzwerk Hämatologie und intern. Onkologie Cologne, Germany
- Evangelisches Krankenhaus Bethesda Duisburg, Germany
- Kliniken Essen Mitte Essen, Germany
Active, Not Recruiting
Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer
NCT07541703
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Medical University of Vienna, Center of Cancer Research Vienna, Austria
Active, Not Recruiting
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
NCT03701334
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
- Locations
-
- University of Alabama at Birmingham-Kirklin Clinic Birmingham, Alabama, United States
- Cancer Treatment Centers of America Goodyear, Arizona, United States
- St Bernards Medical Center Jonesboro, Arkansas, United States
- Comprehensive Blood and Cancer Bakersfield, California, United States
Active, Not Recruiting
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
NCT04293393
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
- Locations
-
- Complejo Hospitalario Universitario de Santiago (CHUS) Santiago de Compostela, A Coruña, Spain
- Institut Català d'Oncología (ICO) L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
- Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
- Consorcio Hospitalario Provincial de Castellón Castellon, Castelló, Spain
Active, Not Recruiting
De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer
NCT07421141
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- P.A. Hertsen Moscow Oncology Research Institute Moscow, Russia
Active, Not Recruiting
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
NCT02308085
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
- Locations
-
- Cedars Sinai Medical Centre Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- Sharp Memorial Hospital San Diego, California, United States
- University of Colorado Cancer Centre - Anschutz Cancer Pavilion Aurora, Colorado, United States